A Phase II, randomised, double-blind, placebo-controlled, dose-finding study of BI 456906 in people living with overweight/obesity

被引:0
|
作者
Le Roux, C. W. [1 ]
Steen, O. [2 ]
Lucas, K. J. [3 ]
Borowska, L. [4 ]
Unseld, A. [5 ]
Startseva, E. [4 ]
机构
[1] Univ Coll Dublin, Sch Med, Dublin, Ireland
[2] LMC Diabet & Endocrinol, Toronto, ON, Canada
[3] Diabet & Endocrinol Consultants PC, Morehead City, NC USA
[4] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[5] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
59
引用
收藏
页码:S32 / S33
页数:2
相关论文
共 50 条
  • [1] A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity
    Le Roux, M. Carel W.
    Steen, Oren
    Lucas, Kathryn J.
    Startseva, Elena
    Borowska, Luiza
    Unseld, Anna
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 153
  • [2] A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of BI 456906 in People with Overweight/Obesity
    Le Roux, Carel
    Steen, Oren
    Lucas, Kathryn J.
    Startseva, Elena
    Unseld, Anna
    Hennige, Anita M.
    [J]. DIABETES, 2023, 72
  • [3] A DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-FINDING STUDY WITH SERTRALINE
    AMIN, M
    LEHMANN, H
    MIRMIRAN, J
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 1989, 25 (02) : 164 - 167
  • [4] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
    Lau, David C. W.
    Erichsen, Lars
    Francisco, Ann Marie
    Satylganova, Altynai
    le Roux, Carel W.
    McGowan, Barbara
    Pedersen, Sue D.
    Pietilainen, Kirsi H.
    Rubino, Domenica
    Batterham, Rachel L.
    [J]. LANCET, 2021, 398 (10317): : 2160 - 2172
  • [5] DOSE-FINDING OF LINACLOTIDE FOR PATIENTS WITH CHRONIC CONSTIPATION IN JAPAN: A PHASE II RANDOMIZED, DOUBLE-BLIND, AND PLACEBO-CONTROLLED STUDY
    Fukudo, Shin
    Miwa, Hiroto
    Nakajima, Atsushi
    Kinoshita, Yoshikazu
    Kosako, Masanori
    Nakagawa, Ayako
    Akiho, Hiraku
    Kuroishi, Kentarou
    Johnston, Jeffrey M.
    Currie, Mark
    Ohkusa, Toshifumi
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S515 - S516
  • [6] Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease
    Coleman, RE
    Purohit, OP
    Black, C
    Vinholes, JJF
    Schlosser, K
    Huss, H
    Quinn, KJ
    Kanis, J
    [J]. ANNALS OF ONCOLOGY, 1999, 10 (03) : 311 - 316
  • [7] Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
    Genovese, Mark C.
    Durez, Patrick
    Richards, Hanno B.
    Supronik, Jerzy
    Dokoupilova, Eva
    Mazurov, Vadim
    Aelion, Jacob A.
    Lee, Sang-Heon
    Codding, Christine E.
    Kellner, Herbert
    Ikawa, Takashi
    Hugot, Sophie
    Mpofu, Shephard
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (06) : 863 - 869
  • [8] Dose-finding study of linaclotide in Japanese patients with chronic constipation: A phase II randomized, double-blind, and placebo-controlled study
    Fukudo, Shin
    Miwa, Hiroto
    Nakajima, Atsushi
    Kinoshita, Yoshikazu
    Kosako, Masanori
    Nakagawa, Ayako
    Akiho, Hiraku
    Kuroishi, Kentaro
    Johnston, Jeffrey M.
    Currie, Mark
    Ohkusa, Toshifumi
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30 (12):
  • [9] Placebo-controlled, double-blind dose-finding study of entacapone in fluctuating parkinsonian patients
    Mizuno, Yoshikuni
    Kanazawa, Ichiro
    Kuno, Sadako
    Yanagisawa, Nobuo
    Yamamoto, Mitsutoshi
    Kondo, Tomoyoshi
    [J]. MOVEMENT DISORDERS, 2007, 22 (01) : 75 - 80
  • [10] Double-Blind, Randomized, Placebo-Controlled Phase II Dose-Finding Study To Evaluate High-Dose Rifampin for Tuberculous Meningitis
    Dian, S.
    Yunivita, V.
    Ganiem, A. R.
    Pramaesya, T.
    Chaidir, L.
    Wahyudi, K.
    Achmad, T. H.
    Colbers, A.
    te Brake, L.
    van Crevel, R.
    Ruslami, R.
    Aarnoutse, R.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (12)